Viewing Study NCT06764693


Ignite Creation Date: 2025-12-25 @ 1:03 AM
Ignite Modification Date: 2026-01-03 @ 1:29 AM
Study NCT ID: NCT06764693
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2025-01-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
Sponsor: AbbVie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module